Eastman Kodak Co said plan sell 2.3 pct holding ICN Pharmaceuticals & lt ; ICN > part nine pct holding Viratek & lt ; VIRA > .
It said purpose investment lay groundwork creation Nucleic Acid Research Institute .
Since achieved , longer reason maintain equity position , Kodak said .
Kodak hold 470,000 sahres ICN , currently trading 18-3/4 700,000 Viratek , trading 44 .
Reuter & # 3 ; 